Novel implant and novel vector for the treatment of acquired diseases
First Claim
Patent Images
1. Implant of genetically modified cells comprising an exogenous nucleotide sequence encoding all or part of an antibody, the said exogenous nucleotide sequence being placed under the control of the elements necessary for its expression and for the secretion of the said antibody.
1 Assignment
0 Petitions
Accused Products
Abstract
Genetically modified cell implant comprising an exogenous nucleotide sequence coding for all or part of an antibody, method for the preparation of such an implant and its therapeutic use for the treatment or prevention of an acquired disease. The invention also concerns an adenoviral vector, a pharmaceutical composition and its therapeutic use.
17 Citations
37 Claims
- 1. Implant of genetically modified cells comprising an exogenous nucleotide sequence encoding all or part of an antibody, the said exogenous nucleotide sequence being placed under the control of the elements necessary for its expression and for the secretion of the said antibody.
-
15. Recombinant adenoviral vector comprising an exogenous nucleotide sequence encoding all or part of one or more protein(s) of interest capable of forming a multimer in a host cell;
- the said exogenous nucleotide sequence being placed under the control of the elements necessary for its expression.
- View Dependent Claims (23, 24, 29, 30, 31, 32, 33, 34, 35, 36, 37)
-
18. Recombinant adenoviral vector comprising an exogenous nucleotide sequence encoding all or part of an antibody;
- the said exogenous nucleotide sequence being placed under the control of the elements necessary for its expression.
Specification